Valeant, Bill Ackman bid $45B for Botox-maker Allergan

April 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45 billion US — if they overcome the California-based specialty drug company's reluctance.

Click here for the article.

Share This Story